Table 2 Descriptive statistics of adjuvant endocrine cohort (n=3361) by adherence
From: Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
Low adherence (%) | High adherence (%) | χ 2 -test (Pearson’s, d.f., P -value) | |
|---|---|---|---|
Numbers | 576 (17) | 2785 (83) | — |
SIMD quintile | |||
1 | 89 (16) | 364 (13) | 9.7; 4; 0.044 |
2 | 88 (15) | 387 (14) | — |
3 | 109 (19) | 436 (16) | — |
4 | 164 (29) | 932 (34) | — |
5 | 120 (21) | 618 (23) | — |
Unknown | 6 | 48 | — |
Age group | |||
<40 | 45 (8) | 88 (3) | 41.8; 5; <0.0001 |
40–49 | 94 (16) | 363 (13) | — |
50–59 | 149 (26) | 643 (23) | — |
60–69 | 114 (20) | 657 (24) | — |
70–79 | 90 (16) | 579 (21) | — |
80+ | 84 (14) | 455 (16) | — |
Charlson’s index | |||
0–2 | 179 (31) | 833 (30) | 0.4; 2; 0.809 |
3–5 | 227 (39) | 1098 (39) | — |
6+ | 170 (30) | 854 (31) | — |
Tumour stage | |||
1 | 152 (44) | 640 (43) | 6.8; 3; 0.077 |
2 | 111 (33) | 541 (36) | — |
3 | 36 (11) | 101 (7) | — |
4 | 43 (12) | 206 (14) | — |
Unknown | 234 | 1297 | — |
Clinical nodes | |||
0 | 353 (80) | 1591 (82) | 0.5; 2; 0.785 |
1 | 73 (17) | 298 (15) | — |
2 | 12 (3) | 52 (3) | — |
Unknown | 138 | 844 | — |
Clinical metastases | |||
No | 410 (94) | 1796 (96) | 1; 1; 0.320 |
Yes | 24 (6) | 83 (4) | — |
Unknown | 142 | 906 | — |
Tumour grade | |||
1 | 70 (17) | 325 (15) | 2.5; 2; 0.282 |
2 | 201 (48) | 1139 (52) | — |
3 | 150 (35) | 731 (33) | — |
Unknown | 155 | 590 | — |
ER status | |||
Positive | 362 (90) | 1958 (92) | 3.9; 1; 0.050 |
Negative | 42 (10) | 159 (8) | |
Unknown | 172 | 668 | |
